MRCY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Mercury Systems Inc (MRCY) is not a strong buy for a beginner investor with a long-term horizon and $50,000-$100,000 available for investment. While the technical indicators show some bullish momentum, the company's financial performance is weak, with declining net income, EPS, and gross margin. Additionally, hedge funds are selling, and there are ongoing legal investigations, which could create uncertainty. The lack of a strong AI Stock Picker signal and the mixed analyst ratings further support a cautious approach.
The technical indicators suggest a short-term bullish trend. The MACD is positive and expanding, the RSI is neutral at 60.055, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above the pivot point of 75.696, with resistance levels at 80.931 and 84.166.
SwingMax sent an entry signal on 2026-04-06, with a 3.68% price increase since then.
Some analysts, such as RBC Capital, Truist, and Canaccord, have raised their price targets and maintain Buy or Outperform ratings, citing strong execution and robust Q2 earnings.
Hedge funds are selling, with a 387.56% increase in selling activity last quarter.
Legal investigations into potential breaches of fiduciary duties by Mercury Systems' officers could create uncertainty.
Weak financial performance, with declining net income (-14.13% YoY), EPS (-16.67% YoY), and gross margin (-1.75% YoY).
In Q2 2026, revenue increased by 4.37% YoY to $232.87M, but net income dropped to -$15.09M (-14.13% YoY), EPS fell to -0.25 (-16.67% YoY), and gross margin declined to 21.87% (-1.75% YoY).
Analyst ratings are mixed. Jefferies recently lowered the price target to $80 and maintained a Hold rating, citing low growth guidance. However, RBC Capital, Truist, and Canaccord raised their price targets to $105, $109, and $102, respectively, and maintain Buy or Outperform ratings, citing strong execution and Q2 earnings beat. Goldman Sachs maintains a Sell rating with a price target of $55, citing margin risks.
